Livagen
๐น What is Livagen?
Class: Synthetic tetrapeptide (Lys-Glu-Asp-Ala), structurally related to Epitalon, part of the Khavinson-style Russian peptide bioregulator family. Mechanism:
- Loosens age-condensed chromatin, which may allow genes that had gone quiet with age to switch back on.
- Acts on lymphocytes to support broader immune activity, with knock-on effects proposed across cardiovascular, digestive, and central nervous systems.
- Interferes with the enzymes that break down enkephalins, which may shift pain perception and stress response.
Primary focus:
- Cellular-level anti-aging support through gene re-expression and chromatin remodeling.
- Secondary immune support and a possible role in stress resilience and pain modulation via the enkephalin pathway.
๐น Subcutaneous Injection (primary route in research) Range: 10โ15 mg daily, typically for 10โ20 days depending on the protocol and individual response. Rationale: Most of the research behind Livagen used injectable administration; this is the route with the more established dosing pattern.
๐น Oral Capsule Dosage (less common) Notes: Oral versions exist, but bioavailability is generally considered lower than the injectable route for this particular bioregulator โ worth factoring in if oral is the only practical option.
๐น Cycle Length Common cycle length: 10โ20 days per course. Off-cycle: As with other bioregulators in this family, short defined courses with rest periods between them are the norm rather than continuous daily use.
๐น Optimal Dosing Window
- Daily dosing across the course window is standard; no strong timing preference (morning vs. evening) is emphasized in the available material.
- Given the immune and stress-response angles, some choose to run a course during periods of elevated physical or immune stress.
โ Educational Integration Example (subcutaneous)
- Example protocol: 10โ15 mg subcutaneous daily for 15 days, used as a short seasonal course for general cellular and immune support.
- Often discussed alongside Epitalon given the structural relationship between the two peptides.
๐น Stacking Strategy (Educational / Complementary) Since Livagen is focused on gene re-expression, chromatin health, and immune support, complementary stacking tends to lean toward longevity and immune-modulating peptides: ๐ธ Longevity & Cellular Support:
- Epitalon: Closely related tetrapeptide with overlapping anti-aging and cellular mechanisms.
๐ธ Immune-Focused Bioregulators:
- Thymogen, Vladonix, Crystagen: Immune-modulating bioregulators that may complement Livagenโs lymphocyte-supportive action.
Rationale: Livagen operates at the level of gene expression and immune cell activity; stacking aims to reinforce cellular longevity and immune resilience across complementary pathways.
Studied in Humans? Limited (primarily Russian/Eastern European research, minimal Western clinical trials)
FDA Approved? No
Allowed for 503a Compounding Pharmacy? No
Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.